Malignant Ascites
📧 Sign up to get email alerts when something new happens for Malignant Ascites.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
A completed Travera Inc trial evaluating TraveraRTGx and a tumor-cell biomarker intended to guide rapid therapy decisions across multiple ca…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: At-Home Paracentesis for Women With Cancer-Related Malignant Ascites (Paracentesis) [NA]
This clinical trial update describes at-home paracentesis for women with cancer-related malignant ascites, and the study is currently not ye…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: PMCF Study of the CE-marked Drainova® ArgentiC Catheter
This PMCF study of the CE-marked Drainova ArgentiC Catheter by ewimed GmbH has completed. It evaluated its use for pleural effusion (includi…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing intraperitoneal liposomal irinotecan as monotherapy or in combination with recombinant mutant human tumor…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Clinical Study of GK02 in Malignant Ascites [EARLY_Phase 1]
An early-phase clinical trial investigates GK02 for malignant ascites caused by advanced solid tumors; the study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites [Phase 1, Phase 2]
A Phase 1/2 clinical trial is testing intraperitoneal immune checkpoint inhibitors with zoledronic acid for gastric cancer with malignant as…
-
EMA approval · 2025-09-24EMA Authorised: Korjuny (catumaxomab) — Atnahs Pharma Netherlands B.V.
The European Medicines Agency authorised Korjuny (catumaxomab) by Atnahs Pharma Netherlands B.V. for the treatment of malignant ascites.
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: QOL and Sarcopenia in Patients With Ascites
A clinical trial is ongoing to assess quality of life and sarcopenia in patients with hepatic and malignant ascites; recruitment is currentl…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions [Phase 2]
A Phase 2 trial comparing bevacizumab plus cisplatin against cisplatin alone for malignant serous effusions is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody [Phase 3]
A Phase 3 clinical trial is evaluating M701 Bispecific Antibody for malignant ascites caused by advanced epithelial solid tumors. The study …
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: A Study of M701 (EpCAM and CD3) in Malignant Ascites [Phase 1]
A Phase 1 study of M701, an EpCAM-CD3 bispecific T-cell engager, in malignant ascites has completed; sponsor is Wuhan YZY Biopharma Co., Ltd…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: A Phase I Study of SIM0388 in Participants With Malignant Ascites. [Phase 1]
This is a Phase I clinical trial evaluating SIM0388 in participants with malignant ascites; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites [Phase 1, Phase 2]
A Phase 1/2 trial evaluating SK-NK Injection in patients with advanced solid tumors and malignant ascites; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer [Phase 1]
Phase 1 trial evaluating delivery of tocilizumab via pleural and peritoneal catheters in patients with advanced metastatic cancer, including…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: International Alfapump Cohort Study
Update on the International Alfapump Cohort Study showing the trial is active but not recruiting, sponsored by Sequana Medical N.V., for liv…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites [Phase 2]
Phase 2 trial evaluating the combination of bevacizumab, serplulimab, and rmhTNF-NC for malignant ascites; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites [Phase 1]
A Phase 1 clinical trial update evaluating NK042 for malignant ascites in gynecologic cancer reports safety findings and preliminary efficac…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites [Phase 2]
Phase 2 clinical trial update evaluating intraperitoneal injection of oncolytic virus H101 for refractory malignant ascites has completed.
-
CLINICAL_TRIALS research · 2022-08-15Clinical Trial Update: PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites [Phase 1, Phase 2]
A clinical trial exploring intraperitoneal perfusion of a PD-1 inhibitor combined with PRaG therapy for malignant ascites in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites [Phase 1, Phase 2]
A clinical trial update for Syngenon (BSG-001) in inhalation therapy for malignant pleural effusion and malignant ascites across Phase 1 and…
-
CLINICAL_TRIALS research · 2018-06-11Clinical Trial Update: Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis
This clinical trial update investigates quality of life in patients with malignant ascites treated with rocket indwelling pleural catheter d…
-
CLINICAL_TRIALS research · 2018-06-08Clinical Trial Update: EUS-Guided Drainage of Refractory Malignant Ascites
This is an ongoing clinical trial evaluating endoscopic ultrasound-guided drainage for refractory malignant ascites, sponsored by Hospital U…
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites
A retrospective analysis assessed the use of the Alfapump for treating malignant ascites, summarizing outcomes and safety from the completed…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites [Phase 2]
Phase 2 trial of mitomycin delivered via hyperthermic peritoneal perfusion for malignant ascites due to metastatic cancer, terminated.
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: A Tolerance Trial of Cinobufacini Injection Intraperitoneal Perfusion on Digestive System Cancer With Ascites [Phase 1]
Phase 1 tolerance study evaluating intraperitoneal perfusion of Cinobufacini Injection in digestive system cancers with malignant ascites; c…